HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Han Selected Research

sanshool

12/2022Design of hydroxy-α-sanshool loaded nanostructured lipid carriers as a potential local anesthetic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Han Research Topics

Disease

56Neoplasms (Cancer)
01/2022 - 11/2008
21Infections
08/2021 - 09/2003
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018 - 11/2008
18Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 12/2005
16Lung Neoplasms (Lung Cancer)
11/2018 - 11/2007
11COVID-19
01/2022 - 01/2020
10Carcinogenesis
01/2022 - 05/2015
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2013
9Neoplasm Metastasis (Metastasis)
01/2017 - 11/2008
8Coinfection
12/2020 - 01/2011
6Body Weight (Weight, Body)
05/2022 - 08/2010
6Disease Progression
01/2020 - 02/2006
6Colorectal Neoplasms (Colorectal Cancer)
05/2018 - 12/2013
6HIV Infections (HIV Infection)
01/2017 - 12/2010
5Alzheimer Disease (Alzheimer's Disease)
02/2021 - 11/2018
5Lymphatic Metastasis
11/2020 - 03/2009
5Lipodystrophy
01/2014 - 10/2006
4Hepatocellular Carcinoma (Hepatoma)
08/2021 - 01/2019
4Stroke (Strokes)
01/2020 - 09/2011
4Inflammation (Inflammations)
01/2020 - 04/2015
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2019 - 02/2016
3Pain (Aches)
12/2022 - 12/2010
3Pneumonia (Pneumonitis)
01/2022 - 01/2012
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2019
3Mitochondrial Diseases (Mitochondrial Disease)
02/2021 - 01/2020
3Papillomavirus Infections
01/2021 - 09/2018
3Glioblastoma (Glioblastoma Multiforme)
01/2019 - 11/2013
3Fibrosis (Cirrhosis)
11/2018 - 02/2016
2Starvation
06/2022 - 05/2018
2Type 2 Diabetes Mellitus (MODY)
05/2022 - 07/2019
2Hypoxia (Hypoxemia)
04/2022 - 03/2020
2Hypotension (Low Blood Pressure)
01/2022 - 04/2005
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2021
2Choanal Atresia
11/2021 - 08/2021
2Wounds and Injuries (Trauma)
08/2021 - 03/2013
2Viremia
06/2021 - 06/2020
2Hypertension (High Blood Pressure)
06/2020 - 01/2018
2Otitis Media with Effusion
08/2019 - 12/2013
2Atherosclerosis
07/2019 - 12/2010
2Reperfusion Injury
01/2019 - 11/2017
2Chronic Hepatitis B
01/2019 - 09/2014
2Hemorrhage
12/2017 - 04/2011
2Leukemia
12/2017 - 05/2016
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2017 - 03/2014
2Infarction (Infarctions)
11/2017 - 03/2014
2Breast Neoplasms (Breast Cancer)
06/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

24Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2006
11DNA (Deoxyribonucleic Acid)IBA
06/2021 - 06/2011
11Messenger RNA (mRNA)IBA
11/2020 - 04/2008
11CytokinesIBA
01/2020 - 09/2003
10Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2013
8Pharmaceutical PreparationsIBA
01/2022 - 07/2006
8Biological ProductsIBA
11/2018 - 04/2008
7Glucose (Dextrose)FDA LinkGeneric
05/2022 - 04/2009
5LipidsIBA
05/2022 - 04/2009
5Long Noncoding RNAIBA
01/2022 - 03/2020
5RNA (Ribonucleic Acid)IBA
01/2022 - 07/2006
4MicroRNAs (MicroRNA)IBA
01/2022 - 01/2015
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 09/2003
4VaccinesIBA
01/2021 - 12/2006
4Indicators and Reagents (Reagents)IBA
01/2021 - 10/2009
4Small Interfering RNA (siRNA)IBA
10/2016 - 10/2012
4matrigelIBA
08/2016 - 11/2007
4Nevirapine (Viramune)FDA Link
01/2013 - 01/2008
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 11/2019
3Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2020
3Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2015
3Phosphotransferases (Kinase)IBA
01/2021 - 10/2015
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 03/2020
3Zidovudine (Retrovir)FDA LinkGeneric
06/2020 - 08/2007
3LigandsIBA
01/2020 - 01/2019
3Interleukin-17 (Interleukin 17)IBA
03/2019 - 12/2012
3CateninsIBA
01/2017 - 10/2012
3Therapeutic UsesIBA
03/2014 - 05/2004
3Stavudine (Zerit)FDA LinkGeneric
01/2014 - 05/2011
3Cadherins (E-Cadherin)IBA
10/2012 - 03/2009
3beta CateninIBA
08/2010 - 11/2008
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2021
2AlginatesIBA
12/2021 - 10/2019
2OligosaccharidesIBA
12/2021 - 10/2019
2SteroidsIBA
11/2021 - 08/2021
2CyclinsIBA
08/2021 - 09/2013
2MicellesIBA
06/2021 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2021 - 12/2020
2Nucleic AcidsIBA
12/2020 - 07/2020
2AntioxidantsIBA
11/2020 - 12/2017
2Reverse Transcriptase InhibitorsIBA
06/2020 - 11/2012
2Tenofovir (Viread)FDA Link
06/2020 - 01/2015
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 02/2006
2Interleukin-18 (Interleukin 18)IBA
03/2019 - 01/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 11/2018
2Cyclin D1IBA
06/2017 - 01/2016
2GTPase-Activating Proteins (GTPase-Activating Protein)IBA
06/2017 - 01/2014

Therapy/Procedure

28Therapeutics
01/2022 - 06/2006
16Highly Active Antiretroviral Therapy (HAART)
02/2016 - 12/2005
11Drug Therapy (Chemotherapy)
01/2022 - 12/2013
6Radiotherapy
02/2021 - 10/2012
4Art Therapy
01/2017 - 04/2013
3Stents
11/2021 - 11/2020
3Aftercare (After-Treatment)
07/2019 - 12/2010